Genkyotex was joined in the series C round extension by private equity firmEdmond de Rothschild Investment Partners, venture firm Vesalius Biocapital Partners, and incubator Eclosion.
MP Healthcare Venture Management, a life sciences venture capital firm affiliated with Japan’s Mitsubishi Tanabe Pharma Corporation and Mitsubishi Chemical Holdings Corporation, has helped Genkyotex, a Switzerland-based healthcare company, raise CHF25m ($26m).
MP Healthcare Venture Management was joined in the series C round extension by private equity firmEdmond de Rothschild Investment Partners, venture firm Vesalius Biocapital Partners, and incubator Eclosion.
Genkyotex has also appointed Eric Meldrum as Chief Scientific Officer, while Alexandre Grassin has joined Genkyotex as finance director.
Last…
